Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Wide Variety of Gels Can Now Be Analyzed With One Imaging System

By BiotechDaily International staff writers
Posted on 27 Mar 2013
Image: GelDoc-Ite, the new imaging system for gel documentation from UVP (Photo courtesy of UVP, LLC).
Image: GelDoc-Ite, the new imaging system for gel documentation from UVP (Photo courtesy of UVP, LLC).
A new high-quality gel imager provides flexible, simple, efficient, and economical imaging, analysis, and documentation within a single system.

UVP, LLC (UVP; Upland, CA, USA) introduces its new “GelDoc-Ite Imager” designed for fast, simple imaging of various gel types. This imager "provides researchers with a resourceful and economical system [while] hardware features facilitate ease of use [...]. Side access doors are conveniently located for cutting or moving gels, a UV-safe gel viewer window enables viewing of illuminated gels, and a camera and zoom lens configuration captures large gels or zooms in on details," said UVP management team member Mike Capps.

The integrated UV transilluminator accommodates a wide range of gel sizes and samples are illuminated with a choice of transilluminator for maximizing fluorophore stain excitation. A unit with midrange 302 nm UV is for viewing ethidium bromide (EtBr) and other stains, while the 3UV model provides user-selectable 302, 365, and 254 nm excitation. An EtBr emission filter is included as standard with the GelDoc-Ite, while a variety of optional emission filters are available to suit various applications. The modular design enables placement of converter plates onto the UV transillumination surface, converting midrange UV to specific wavelengths for illumination of a variety of stains. The “Visi-Blue” Converter Plate converts the UV to 460–470 nm blue light for viewing stains such as SYBR Green, SYBR Safe, and GelGreen. When white light transillumination is required, the White Light Converter Plate can be used for viewing gels such as Coomassie Blue and Silver stain.

GelDoc-Ite simplifies imaging with the intuitive, workflow-based “VisionWorks LS” software. Easy-to-use one-touch buttons enable fast image acquisition, while the software controls the scientific grade CCD camera, which captures high quality, publication-ready images. Researchers can conduct 1D analysis and generate extensive quantitative data using molecular weight, histograms, lane profile graphs and other tools. Once analysis is complete, exporting result data to Excel and other programs for documentation and publication is accomplished with the software's integrated export tools.

With its compact size, the GelDoc-Ite Imager greatly reduces lab bench-space requirements and, with its user-friendly system, minimal operator training is required. Its design enables researchers to easily view gels using multiple light sources, to quickly capture and save publication-quality images, and to analyze lanes and bands. Fluorescent, colorimetric, or blue light imaging of a wide variety of gels can now be satisfied within this single system.

Related Links:

UVP, LLC
GelDoc-Ite



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: This novel, flexible film that can react to light is a promising step toward an artificial retina (Photo courtesy of the American Chemical Society).

Novel Nanofilm May Be Artificial Retina Precursor

Researchers have used advanced nanotechnology techniques to develop a light-sensitive film that has potential for future artificial retina applications. Investigators at the Hebrew University of Jerusalem... Read more

Drug Discovery

view channel
Image: The new peptide offers a triple hormone effect in a single-cell molecule (Photo courtesy of Indiana University).

Tripeptide Drug Effectively Controls Metabolic Syndrome in Rodent Model

Promising results in reducing obesity and normalizing glucose metabolism obtained with a synthetic dipeptide drug have been enhanced by the addition of a molecule of a third hormone, glucagon.... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.